BMT CTN Protocol 0901

A Randomized, Multi-Center, Phase III Study of Allogeneic Stem Cell Transplantation Comparing Regimen Intensity in Patients with Myelodysplastic Syndrome or Acute Myeloid Leukemia

Below are protocol-related documents, which may be periodically updated.

• Protocol Synopsis, version 5.0 dated March 3, 2014
• Protocol, version 5.0 dated March 3, 2014
• Summary of Changes from version 4.0 to 5.0
• Informed consent, version 5.0 dated March 3, 2014
• Participating Centers
• Frequently Asked Questions
• This study is posted on clinicaltrials.gov as NCT01339910
• Key Personnel

            Protocol Co-Chair: Mitchell Horwitz, MD (919-668-1045) mitchell.horwitz@duke.edu

            Protocol Co-Chair: Bart Scott, MD (206-667-1990) bscott@fhcrc.org

            Protocol Officer: Marcello Pasquini, MD (414-805-0700) mpasquin@mcw.edu

            Acting Protocol Coordinator: Brianne Allison (301-251-1161) ballison@emmes.com

            Medical Monitor: Bipin Savani, MD bipin.savani@vanderbilt.edu

        

           

The BMT CTN is committed to including widespread transplant community participation in these trials. However, due to the limited resources, not all requests can be accommodated for each protocol. If your center is interested in participating, please fax the completed Affiliate Center Application, or you may complete the short form if currently participating as an affiliate center in any other BMT CTN trial, to BMT CTN DCC/EMMES at 301-251-1355